Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Javelin Pharmaceuticals Inc.

Division of Pfizer Inc.
www.javelinpharmaceuticals.com

Latest From Javelin Pharmaceuticals Inc.

Distortion And Inflation In Measuring Pharma M&A

Five companies in big pharma’s top 20 have come through mergers in the past 10 years or so that changed them significantly. As measured by standard financial performance parameters, the processes at Takeda and Teva (and to some extent, at Allergan) seem relatively smooth and productive. Those at Pfizer and Merck don’t. But it depends on how you look at the numbers.

Deals Business Strategies

A Busy Year-End, In Brief: December Brings Slate Of Approvals, And Setbacks

In addition to a spate of FDA approvals closing out the year, Roche contended with trial failures and Actavis received a “complete response” letter for its nebivolol/valsartan combination.

BioPharmaceutical United States

Asmacure appoints Martin Driscoll CEO

Asmacure, a clinical-stage biopharma company focused on the development of nicotinic receptor agonists for the treatment of asthma and other inflammatory diseases, has appointed Martin Driscoll chief executive officer. Mr Driscoll was previously CEO and a director of Javelin Pharmaceuticals and will succeed Dr Luc Vachon, who is leaving the company to pursue other business ventures.

Respiratory

Hospira's CEO and COO to step down

Hospira's CEO Christopher Begley and chief operational officer Terrence Kearney are to resign from their positions, having both served at the company since its foundation in 2004.

Companies
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
      • Nasal
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Intrac Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Pfizer Inc.
  • Senior Management
  • Stephen J Tulipano, CFO
    Daniel B Carr, MD, Pres. & CMO
    John C Taylor, VP, Bus. Dev.
  • Contact Info
  • Javelin Pharmaceuticals Inc.
    Phone: (617) 349-4500
    125 CambridgePark Dr.
    Cambridge, MA 02140
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register